1. Home
  2. NEUE vs BRNS Comparison

NEUE vs BRNS Comparison

Compare NEUE & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUE
  • BRNS
  • Stock Information
  • Founded
  • NEUE 2015
  • BRNS 2016
  • Country
  • NEUE United States
  • BRNS United Kingdom
  • Employees
  • NEUE N/A
  • BRNS N/A
  • Industry
  • NEUE
  • BRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEUE
  • BRNS Health Care
  • Exchange
  • NEUE NYSE
  • BRNS Nasdaq
  • Market Cap
  • NEUE 42.7M
  • BRNS 36.7M
  • IPO Year
  • NEUE 2021
  • BRNS 2021
  • Fundamental
  • Price
  • NEUE $4.13
  • BRNS $1.17
  • Analyst Decision
  • NEUE Hold
  • BRNS Strong Buy
  • Analyst Count
  • NEUE 1
  • BRNS 2
  • Target Price
  • NEUE $7.00
  • BRNS $4.00
  • AVG Volume (30 Days)
  • NEUE 8.4K
  • BRNS 69.8K
  • Earning Date
  • NEUE 11-07-2024
  • BRNS 11-06-2024
  • Dividend Yield
  • NEUE N/A
  • BRNS N/A
  • EPS Growth
  • NEUE N/A
  • BRNS N/A
  • EPS
  • NEUE N/A
  • BRNS N/A
  • Revenue
  • NEUE $996,890,000.00
  • BRNS $14,969,000.00
  • Revenue This Year
  • NEUE N/A
  • BRNS $1,805.74
  • Revenue Next Year
  • NEUE $9.44
  • BRNS N/A
  • P/E Ratio
  • NEUE N/A
  • BRNS N/A
  • Revenue Growth
  • NEUE N/A
  • BRNS 106.21
  • 52 Week Low
  • NEUE $4.00
  • BRNS $0.80
  • 52 Week High
  • NEUE $16.59
  • BRNS $4.16
  • Technical
  • Relative Strength Index (RSI)
  • NEUE 36.27
  • BRNS 57.61
  • Support Level
  • NEUE $3.99
  • BRNS $0.80
  • Resistance Level
  • NEUE $5.18
  • BRNS $1.05
  • Average True Range (ATR)
  • NEUE 0.34
  • BRNS 0.12
  • MACD
  • NEUE -0.12
  • BRNS 0.03
  • Stochastic Oscillator
  • NEUE 11.77
  • BRNS 100.00

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Share on Social Networks: